{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:52:16Z","timestamp":1783075936173,"version":"3.54.6"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ajp.2021.102694","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T12:33:57Z","timestamp":1621600437000},"page":"102694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Study on the relationship among dose, concentration and clinical response in Chinese schizophrenic patients treated with Amisulpride"],"prefix":"10.1016","volume":"62","author":[{"given":"Fengli","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"49","key":"10.1016\/j.ajp.2021.102694_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21490","article-title":"Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness","volume":"21","author":"Barnes","year":"2017","journal-title":"Health Technol. Assess."},{"issue":"3","key":"10.1016\/j.ajp.2021.102694_bib0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.euroneuro.2003.09.001","article-title":"Plasma amisulpride levels in schizophrenia or schizoaffective disorder","volume":"14","author":"Bergemann","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2021.102694_bib0015","series-title":"Comparative Efcacy and Tolerability of 32 Oral Antipsychotics for the Acute Treatment of Adults With Multi-episode Schizophrenia: a Systematic Review and Network Meta-analysis","author":"Huhn","year":"2019"},{"issue":"10","key":"10.1016\/j.ajp.2021.102694_bib0020","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2215-0366(18)30252-9","article-title":"Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study","volume":"5","author":"Kahn","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"10.1016\/j.ajp.2021.102694_bib0025","first-page":"900","article-title":"New trends in the treatment of schizophrenia","volume":"16","author":"Meltzer","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"8","key":"10.1016\/j.ajp.2021.102694_bib0030","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jpsychires.2005.10.003","article-title":"Herapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia","volume":"41","author":"M\u00fcller","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.ajp.2021.102694_bib0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/0269881108089806","article-title":"Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder","volume":"23","author":"M\u00fcller","year":"2009","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.ajp.2021.102694_bib0040","doi-asserted-by":"crossref","first-page":"250","DOI":"10.9758\/cpn.2019.17.2.250","article-title":"Effects of amisulpride adjunctive therapy on working memory and brain metabolism in the frontal cortex of patients with schizophrenia: a preliminary positron emission Tomography\/Computerized tomography investigation","volume":"17","author":"Park","year":"2019","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"2","key":"10.1016\/j.ajp.2021.102694_bib0045","first-page":"144","article-title":"Relationship between blood drug concentration and clinical efficacy in patients with schizophrenia after taking amisulpride","volume":"26","author":"Ping","year":"2014","journal-title":"Strait Pharmceut. J."},{"issue":"7","key":"10.1016\/j.ajp.2021.102694_bib0050","doi-asserted-by":"crossref","first-page":"e844","DOI":"10.4088\/JCP.16m11216","article-title":"Population approach to guide amisulpride dose adjustments in older patients with Alzheimer\u2019s disease","volume":"78","author":"Reeves","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2021.102694_bib0055","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/gps.4758","article-title":"Herapeutic D2\/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP)","volume":"33","author":"Reeves","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2021.102694_bib0060","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1208\/s12249-018-1079-z","article-title":"Amisulpride-CD-loaded liposomes: optimization and in vivo evaluation","volume":"19","author":"Shukr","year":"2018","journal-title":"AAPS Pharm. Sci. Tech."},{"issue":"6","key":"10.1016\/j.ajp.2021.102694_bib0065","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1600-0447.2009.01429.x","article-title":"Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring","volume":"120","author":"Sparshatt","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ajp.2021.102694_bib0070","doi-asserted-by":"crossref","first-page":"e3928","DOI":"10.1002\/bmc.3928","article-title":"Development of a UPLC\u2010MS\/MS method for routine therapeutic drug monitoring of aripiprazole, amisulpride, olanzapine, paliperidone and ziprasidone with a discussion of their therapeutic reference ranges for Chinese patients","volume":"31","author":"Wang","year":"2017","journal-title":"Biomed. Chromatogr."},{"issue":"6","key":"10.1016\/j.ajp.2021.102694_bib0075","first-page":"425","article-title":"Expert consensus on the treatment of schizophrenia with Amisulpride","volume":"31","author":"Ying","year":"2017","journal-title":"Chin. J. Mental Health"},{"issue":"2","key":"10.1016\/j.ajp.2021.102694_bib0080","first-page":"113","article-title":"The efficacy and safety of amisulpride in the treatment of acute exacerbation patients with schizophrenia","volume":"51","author":"Yunlong","year":"2018","journal-title":"Chin. J. Psychiatry"},{"issue":"23","key":"10.1016\/j.ajp.2021.102694_bib0085","first-page":"2704","article-title":"Research on therapeutic drug monitoring and clinical application of amisulpride tablets","volume":"34","author":"Zhanzhang","year":"2018","journal-title":"Chin. J. Clin. Pharmacol."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201821001507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201821001507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:40:23Z","timestamp":1761756023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201821001507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":17,"alternative-id":["S1876201821001507"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2021.102694","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study on the relationship among dose, concentration and clinical response in Chinese schizophrenic patients treated with Amisulpride","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2021.102694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102694"}}